Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7-8
pubmed:dateCreated
2001-12-25
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0041-1345
pubmed:author
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3195-6
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:11750370-African Americans, pubmed-meshheading:11750370-Aged, pubmed-meshheading:11750370-Calcineurin, pubmed-meshheading:11750370-Demography, pubmed-meshheading:11750370-Drug Therapy, Combination, pubmed-meshheading:11750370-Female, pubmed-meshheading:11750370-Follow-Up Studies, pubmed-meshheading:11750370-Graft Rejection, pubmed-meshheading:11750370-Graft Survival, pubmed-meshheading:11750370-Humans, pubmed-meshheading:11750370-Immunosuppressive Agents, pubmed-meshheading:11750370-Kidney Transplantation, pubmed-meshheading:11750370-Male, pubmed-meshheading:11750370-Middle Aged, pubmed-meshheading:11750370-Muromonab-CD3, pubmed-meshheading:11750370-Mycophenolic Acid, pubmed-meshheading:11750370-Prednisone, pubmed-meshheading:11750370-Retrospective Studies, pubmed-meshheading:11750370-Time Factors, pubmed-meshheading:11750370-Tissue Donors, pubmed-meshheading:11750370-United States
pubmed:articleTitle
Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival.
pubmed:affiliation
Department of Transplantation, MCP Hahnemann University, Philadelphia, Pennsylvania 19102, USA.
pubmed:publicationType
Journal Article